Loteprednol/tobramycin

Loteprednol/tobramycin, sold under the brand name Zylet, is a fixed-dose combination medication used for the treatment of inflammation of the eye.[1] It is a combination of loteprednol, as the etabonate, a corticosteroid; and tobramycin, an aminoglycoside antibiotic.[1] It is used as drops in the eye.[1]

Loteprednol/tobramycin
Combination of
LoteprednolCorticosteroid
TobramycinAminoglycoside antibiotic
Clinical data
Trade namesZylet
AHFS/Drugs.comMicromedex Detailed Consumer Information
License data
Routes of
administration
Ophthalmic
ATC code
Legal status
Legal status
Identifiers
CAS Number
KEGG

Loteprednol/tobramycin was approved for medical use in the United States in December 2004.[1]

References

edit
  1. ^ a b c d e "Zylet- loteprednol etabonate and tobramycin suspension/ drops". DailyMed. 30 April 2022. Retrieved 25 December 2023.

Further reading

edit